What Drugs Cannot Be Taken With Melatonin?

Melatonin looks harmless on the pharmacy shelf — but pharmacist databases document 354 known drug interactions with melatonin, including 5 classified as major. Most people starting melatonin are also taking at least one other medication, making this one of the most overlooked safety checks in supplement use. This guide covers the 6 highest-risk drug categories, the mechanism behind each interaction, and exactly what to do before you start.

Table of Contents

1. How Melatonin Is Metabolised — and Why It Matters for Drug Interactions
2. Antidepressants: The Fluvoxamine Problem
3. Blood Thinners: Warfarin and Anticoagulants
4. Blood Pressure Medications: Nifedipine and Antihypertensives
5. Sedatives, Benzodiazepines, and CNS Depressants
6. Diabetes Drugs and Immunosuppressants
7. Anticonvulsants and Contraceptive Drugs
8. Why Precise Dose Control Matters When You're on Medication
9. Frequently Asked Questions
10. Conclusion
11. Research References

1. How Melatonin Is Metabolised — and Why It Matters for Drug Interactions

Melatonin does not simply "wear off" on its own schedule. After you take it, your liver processes roughly 80% of it via an enzyme called CYP1A2 — a cytochrome P450 enzyme that also handles dozens of common medications. A 2001 study in the Journal of Clinical Psychopharmacology confirmed that CYP1A2 is responsible for almost all melatonin metabolism, with CYP2C19 playing a much smaller secondary role. This matters because any drug that inhibits CYP1A2 will dramatically slow melatonin clearance — causing it to accumulate to levels far above what you intended to take.

Melatonin's CYP1A2 dependency creates what pharmacologists call a drug-drug interaction risk profile. If a medication competes for or blocks the same liver enzyme, melatonin levels can rise 2-, 5-, or even 17-fold above baseline — even if you took your usual dose. On the other side of the equation, melatonin itself affects blood coagulation, blood pressure, immune function, and blood glucose regulation. These pharmacodynamic effects can either amplify or counteract other medications acting on the same systems. Understanding both types of interaction — metabolic (liver enzyme) and pharmacodynamic (body-system) — is essential before starting melatonin alongside any prescription drug.

2. Antidepressants: The Fluvoxamine Problem

Not all antidepressants interact with melatonin the same way — and this distinction is critical. Fluvoxamine (Luvox), an SSRI prescribed for OCD and depression, is a potent CYP1A2 inhibitor. A pharmacokinetic study published in Clinical Pharmacology & Therapeutics (2000) found that taking just 50mg of fluvoxamine with 5mg of melatonin produced a 17-fold increase in melatonin's area under the concentration-time curve and a 12-fold increase in peak serum concentration. In practical terms: a person on fluvoxamine who takes 1mg of melatonin may experience the equivalent of 12–17mg — with all the associated side effects.

Other SSRIs carry a lower but still meaningful risk. The same 2001 Journal of Clinical Psychopharmacology study tested fluoxetine, paroxetine, citalopram, and sertraline alongside fluvoxamine in human liver microsomes. Fluvoxamine was uniquely potent (Ki = 0.02 µM); the other SSRIs showed far weaker inhibition — but were not zero. Additionally, some SSRIs and SNRIs can, in rare cases, contribute to serotonin syndrome when combined with supplements that affect serotonin pathways. Monoamine oxidase inhibitors (MAOIs) represent a separate, higher-risk category: MAO-inhibiting antidepressants increase melatonin precursors including serotonin and N-acetylserotonin, compounding melatonin's pharmacological effects.

Practical guidance:

• Fluvoxamine + melatonin: avoid this combination or use only under close medical supervision with a very low melatonin dose (0.25–0.5mg)
• Other SSRIs: discuss with your prescriber; monitor for excessive drowsiness, headache, or GI upset
• MAOIs: do not combine with melatonin without explicit medical approval
• Tricyclics (TCAs): interactions exist but are less pharmacokinetically defined; medical review advised

3. Blood Thinners: Warfarin and Anticoagulants

Melatonin has been shown to reduce plasma coagulation factors — the proteins that help blood clot. When combined with anticoagulant medications like warfarin (Coumadin), this can amplify blood-thinning effects and raise the risk of abnormal bleeding. Mayo Clinic's drug reference lists anticoagulants and antiplatelet drugs among the highest-priority interaction categories for melatonin, alongside anticonvulsants and CNS depressants. The clinical concern is not theoretical: several case reports have documented elevated INR (a measure of clotting time) in patients taking both warfarin and melatonin concurrently.

The list of anticoagulant and antiplatelet drugs affected is broad and includes commonly prescribed medications: warfarin (Coumadin), aspirin at therapeutic doses, clopidogrel (Plavix), ticagrelor (Brilinta), rivaroxaban (Xarelto), apixaban (Eliquis), dabigatran (Pradaxa), and enoxaparin (Lovenox). Anyone taking any drug in this category should speak with their prescriber before starting melatonin. Drugs.com's interaction database identifies warfarin as one of melatonin's 5 major-classified interactions — the highest severity level in their system. Regular INR monitoring is essential if this combination is used at all.

4. Blood Pressure Medications: Nifedipine and Antihypertensives

The relationship between melatonin and blood pressure medications is complex — and cuts both ways. For most antihypertensives, the concern is additive hypotension: melatonin can lower blood pressure on its own, and stacking it with blood pressure medication can cause blood pressure to fall too low, producing dizziness, weakness, or fainting — particularly in older adults. ADV Pharmacy's clinical pharmacist team flags older patients on antihypertensives as a population requiring particular caution, since age-related changes in melatonin metabolism slow clearance and extend the hormone's blood pressure effects.

Nifedipine (Procardia, Adalat) — a calcium channel blocker — presents a different and counterintuitive problem. Rather than excessive blood pressure lowering, melatonin appears to compete with nifedipine at calcium channel sites, reducing the drug's effectiveness and paradoxically raising blood pressure. GoodRx's clinical pharmacist summary reports one study in which the nifedipine + melatonin combination raised systolic blood pressure by 6.5 mmHg compared to nifedipine alone — a meaningful increase for anyone whose hypertension is being actively managed. Anyone on nifedipine, or any calcium channel blocker, should discuss this specific interaction with their cardiologist or prescribing physician before using melatonin.

5. Sedatives, Benzodiazepines, and CNS Depressants

Melatonin's primary mechanism is promoting sleep — it reduces alertness and prepares the brain for rest. When combined with other central nervous system (CNS) depressants, this sedative effect compounds. StatPearls (NCBI, updated 2024) explicitly states melatonin should not be combined with benzodiazepines, zolpidem, or eszopiclone — the risk is excessive sedation. The benzodiazepine class includes diazepam (Valium), lorazepam (Ativan), clonazepam (Klonopin), alprazolam (Xanax), and temazepam — drugs prescribed for anxiety, panic disorder, muscle spasms, and insomnia. Adding melatonin on top of any of these increases the total sedative load.

The same additive risk applies to opioid pain medications, antihistamines with sedating effects (diphenhydramine — the active ingredient in Benadryl and many OTC sleep aids), and alcohol. Alcohol is particularly important: not only does it amplify melatonin's sedative effect, but it also disrupts the restorative stages of sleep, working against the very reason most people take melatonin in the first place. At the severe end of this interaction spectrum sits the risk of respiratory depression — though this applies mainly to high-dose combinations involving opioids or other powerful CNS depressants. For most people on a low-dose sedating antihistamine or a single glass of wine, the primary concern is next-day grogginess and impaired driving ability rather than acute danger.

6. Diabetes Drugs and Immunosuppressants

Melatonin receptors are present in the pancreas and influence insulin secretion and glucose regulation — which creates a meaningful interaction risk for people managing diabetes. In a 12-week study of obese individuals, 3mg/day of melatonin significantly reduced both glucose and insulin levels (p<0.05). For someone on insulin, metformin, sulfonylureas, or GLP-1 receptor agonists (like Ozempic/semaglutide), adding melatonin could push blood sugar lower than intended — a hypoglycemia risk. The evidence here is mixed: some trials show no significant blood glucose effect, which means individual response varies. Anyone managing diabetes should monitor their blood glucose more closely for the first 1–2 weeks after starting melatonin and inform their prescribing physician.

Immunosuppressants present a fundamentally different type of conflict. Melatonin is immunostimulatory — it activates the immune system via interleukins IL-1, IL-2, IL-6, and IL-12, as well as T-cell and B-cell pathways. This is normally a beneficial property. But for someone on immunosuppressant therapy after an organ transplant (cyclosporine, tacrolimus, mycophenolate) or for managing an autoimmune disease (rheumatoid arthritis, lupus, Crohn's disease), melatonin's immune activation directly counteracts the drug's intended effect. The NIH's NCCIH notes that melatonin should be avoided entirely by people with autoimmune diseases — and Mayo Clinic concurs. This is one category where "avoid" is not a precaution; it is a firm clinical recommendation.

7. Anticonvulsants and Contraceptive Drugs

Melatonin's relationship with seizure threshold is genuinely complicated by the science. Most large-scale experimental data suggests melatonin has anticonvulsant properties. But a 2011 review in Pharmacological Reports found that melatonin plasma levels are naturally 5–8 times higher at night — precisely when nocturnal seizures most frequently occur — and some clinical evidence suggests melatonin may increase seizure activity in children with neurological disabilities. Mayo Clinic's drug reference specifically flags melatonin as potentially inhibiting anticonvulsant drug effects in this population. Anyone with epilepsy or a seizure disorder should discuss melatonin use with their neurologist before starting — particularly if they are on antiepileptic drugs (AEDs) such as valproate, carbamazepine, or lamotrigine.

Hormonal contraceptives represent a different, lower-severity interaction: oral contraceptives can increase melatonin levels in the body (by inhibiting the same CYP1A2 pathway that clears melatonin), and the combination may produce additive sedative effects or intensify melatonin's typical side effects. This interaction is not a safety emergency — it means a woman on the pill who takes a standard 5mg melatonin dose may experience stronger-than-expected drowsiness or next-day fog. Starting at a lower melatonin dose (0.5–1mg) is a sensible precaution for anyone on hormonal contraceptives. As with all interactions in this article, a conversation with your pharmacist costs nothing and takes under 5 minutes.

8. Why Precise Dose Control Matters When You're on Medication

Most melatonin drug interactions are dose-dependent — the higher the melatonin level in your blood, the more pronounced the interaction. This is especially true for the CYP1A2 interactions (fluvoxamine, contraceptives) where slower clearance means you are effectively taking a much higher dose than intended. It is also true for the pharmacodynamic interactions: the blood pressure impact and the sedation amplification both scale with the amount of melatonin in your system. The most practical risk-reduction step — beyond talking to your doctor — is starting with the lowest effective melatonin dose and only increasing if needed.

This is where BioAbsorb Liposomal Liquid Melatonin offers a meaningful advantage for medication users. Standard melatonin tablets come in fixed doses — typically 5mg or 10mg — that cannot be easily divided. BioAbsorb's liquid format uses a graduated dropper that allows precise increments of approximately 0.25mg, with a full dose of 1.5mg per 1ml dropper. Someone on fluvoxamine (under medical supervision), a blood pressure medication, or a sedative can start at 0.25mg — far below what any tablet allows — and titrate up slowly while monitoring their response. The liposomal delivery system also achieves 80–95% bioavailability, compared to 15–20% for standard tablets — meaning less is genuinely needed to achieve the same sleep effect, which is exactly the right direction for anyone managing interaction risk.

BioAbsorb Nutraceuticals manufactures in a GMP-certified, Health Canada-approved Canadian facility. Every batch is third-party tested, with a Certificate of Analysis (COA) available on request — important for anyone whose pharmacist needs to verify the actual melatonin content. At $29.99 for 100ml (100 servings), the graduated dropper format allows medication users to start conservatively without wasting product at low doses. The formulation is non-GMO, vegan, gluten-free, and free of artificial flavours or colours — a clean profile for individuals who may already be managing complex medication regimens.

Frequently Asked Questions

Can I take melatonin with SSRIs other than fluvoxamine?

Most SSRIs carry a lower interaction risk than fluvoxamine specifically — but lower risk is not zero risk. The 2001 Journal of Clinical Psychopharmacology study confirmed that fluoxetine, paroxetine, citalopram, and sertraline all inhibit CYP1A2 far less potently than fluvoxamine, but the inhibition is not absent. Some melatonin supplements have also been found to contain trace amounts of serotonin — raising a distinct serotonin syndrome risk when combined with SSRIs. Discussing the combination with your prescriber or pharmacist before starting is the right step.

Is melatonin safe if I take a beta-blocker for heart disease?

Beta-blockers (metoprolol, atenolol, propranolol) are actually one of the more interesting cases in the melatonin-drug interaction landscape. Beta-blockers suppress the body's natural melatonin production as a side effect — which is one reason heart patients on beta-blockers often report poor sleep. In this context, GoodRx's pharmacist team notes that melatonin supplementation may actually be more beneficial for people on beta-blockers than for the general population. That said, beta-blockers can also affect melatonin metabolism and clearance; starting at a low dose and informing your cardiologist is still the prudent approach.

What happens if I take melatonin with warfarin by accident?

A single accidental dose is unlikely to cause a serious bleeding event, but you should monitor for signs of unusual bruising or bleeding over the following 24–48 hours and contact your prescribing physician if your next INR check is due. Drugs.com classifies the melatonin-warfarin interaction as major, meaning regular INR monitoring is required if the combination is used on an ongoing basis. Do not use melatonin regularly with warfarin without your doctor's awareness and a monitoring plan in place.

Can I take melatonin if I'm on diabetes medication?

It depends on which diabetes medication and how tightly managed your blood glucose is. Melatonin can lower blood glucose and insulin levels, which could push someone on insulin or sulfonylureas into hypoglycemia. The NIH's NCCIH guidance recommends talking to your healthcare provider before combining melatonin with diabetes medications. If your doctor gives the go-ahead, monitoring your blood glucose more closely in the first 1–2 weeks gives you the data to make an informed decision about whether to continue.

Does the form of melatonin affect interaction risk?

Yes — and this is underappreciated. A 5mg melatonin tablet delivers a fixed, high dose. Because most interaction risks are dose-dependent, a liquid format with graduated dosing allows medication users to start at 0.25mg and titrate up slowly — dramatically reducing peak blood levels compared to a standard tablet. Higher bioavailability also means less melatonin is needed to achieve a sleep effect. BioAbsorb's liposomal liquid melatonin achieves 80–95% bioavailability with a graduated dropper delivering approximately 0.25mg increments — a practical advantage for anyone managing interaction risk alongside other medications.

Conclusion

Melatonin's OTC status makes it easy to underestimate — but with 354 documented drug interactions including 5 major-category ones, it is one of the more pharmacologically active supplements in common use. The highest-priority categories to review before starting are antidepressants (especially fluvoxamine), blood thinners, blood pressure medications (particularly nifedipine), sedatives, diabetes drugs, and immunosuppressants. A pharmacist can screen your complete medication list in under 5 minutes — and starting at the lowest effective dose, using a format that allows precise titration, gives you the greatest margin of safety regardless of which medications you take.

Research References

1. Increased bioavailability of oral melatonin after fluvoxamine coadministration. Clinical Pharmacology & Therapeutics, Vol. 67 (2000). Found that fluvoxamine coadministration raised melatonin serum AUC by 17-fold and peak concentration by 12-fold via CYP1A2 inhibition — the primary pharmacokinetic basis for the fluvoxamine-melatonin interaction.
2. Differential effects of fluvoxamine and other antidepressants on the biotransformation of melatonin. Journal of Clinical Psychopharmacology, Vol. 21 (2001). Confirmed melatonin is almost exclusively metabolised by CYP1A2; fluvoxamine showed uniquely potent inhibition (Ki = 0.02 µM) compared to other SSRIs tested.
3. Melatonin in experimental seizures and epilepsy. Pharmacological Reports, Vol. 63 (2011). Reviewed clinical and experimental data on melatonin's proconvulsive and anticonvulsive properties; found nocturnal melatonin levels are 5–8× higher than daytime levels, correlating with peak seizure risk windows.
4. Melatonin — StatPearls. NCBI Bookshelf, StatPearls Publishing (updated 2024). Clinical reference documenting melatonin's immunostimulatory mechanism (IL-1, IL-2, IL-6, IL-12) and the contraindication with benzodiazepines, zolpidem, and eszopiclone due to excessive sedation risk.
5. Melatonin Drug & Supplement Reference. Mayo Clinic. Peer-reviewed institutional reference covering all major interaction categories: anticoagulants, anticonvulsants, blood pressure medications, CNS depressants, diabetes drugs, contraceptives, and immunosuppressants.
6. Melatonin: What You Need to Know. National Center for Complementary and Integrative Health (NCCIH), NIH (2023). Federal guidance on melatonin safety; recommends medical supervision for people with epilepsy or on blood thinners, and pharmacist review for all medication users before starting melatonin.
7. Melatonin Interactions Checker. Drugs.com (pharmacist-reviewed, 2025). Documents 354 known melatonin drug interactions — 5 major, 340 moderate, 9 minor — including the major-classified warfarin interaction.
8. 9 Melatonin Interactions to Be Aware Of. GoodRx, authored by clinical pharmacists (2024). Pharmacist-written summary documenting the nifedipine systolic blood pressure increase (6.5 mmHg), warfarin coagulation risk, and sedation amplification categories.
9. Contraindications — Melatonin. Phytomelatonin.org. Evidence-based clinical reference documenting the nifedipine calcium channel competition mechanism and the 12-week obese-patient trial showing significant glucose and insulin reduction at 3mg/day melatonin (p<0.05).

About the Author

David Kimbell is a health writer, digital entrepreneur and former aerospace engineer, based in Ottawa, Canada. He loves translating complex science into clear, actionable guidance for consumers seeking evidence-based solutions.

---

Important Disclaimers

Medical Disclaimer: This article provides educational information only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new supplement, especially if you have existing health conditions, take medications, or are pregnant or nursing.

FDA/Health Canada Statement: These statements have not been evaluated by the Food and Drug Administration or Health Canada. This product is not intended to diagnose, treat, cure, or prevent any disease.